SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-252876
Filing Date
2017-08-09
Accepted
2017-08-09 16:45:48
Documents
54
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d359274d10q.htm 10-Q 726057
2 EX-10.3 d359274dex103.htm EX-10.3 17159
3 EX-31.1 d359274dex311.htm EX-31.1 10115
4 EX-31.2 d359274dex312.htm EX-31.2 10059
5 EX-32.1 d359274dex321.htm EX-32.1 6090
  Complete submission text file 0001193125-17-252876.txt   3058194

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pfnx-20170630.xml EX-101.INS 477686
7 XBRL TAXONOMY EXTENSION SCHEMA pfnx-20170630.xsd EX-101.SCH 32939
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pfnx-20170630_cal.xml EX-101.CAL 49225
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfnx-20170630_def.xml EX-101.DEF 105880
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfnx-20170630_lab.xml EX-101.LAB 292632
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfnx-20170630_pre.xml EX-101.PRE 203752
Mailing Address 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address 10790 ROSELLE STREET SAN DIEGO CA 92121 858-352-4400
Pfenex Inc. (Filer) CIK: 0001478121 (see all company filings)

IRS No.: 271356759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36540 | Film No.: 171018525
SIC: 2834 Pharmaceutical Preparations